Matches in Wikidata for { <http://www.wikidata.org/entity/Q67124194> ?p ?o ?g. }
Showing items 1 to 32 of
32
with 100 items per page.
- Q67124194 description "clinical trial" @default.
- Q67124194 description "ensayu clínicu" @default.
- Q67124194 description "klinisch onderzoek" @default.
- Q67124194 description "клінічне випробування" @default.
- Q67124194 description "կլինիկական փորձարկում" @default.
- Q67124194 name "Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma" @default.
- Q67124194 name "Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine" @default.
- Q67124194 type Item @default.
- Q67124194 label "Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma" @default.
- Q67124194 label "Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine" @default.
- Q67124194 prefLabel "Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma" @default.
- Q67124194 prefLabel "Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine" @default.
- Q67124194 P1050 Q67124194-C7E25772-55A6-4B75-A5BE-A0A5FB5AFD9D @default.
- Q67124194 P1132 Q67124194-6F646CCE-8677-4DA4-9AAB-9613C50CCF1A @default.
- Q67124194 P1476 Q67124194-4B3DF6D8-163B-4B2B-992F-20023ED93420 @default.
- Q67124194 P2899 Q67124194-D61F3E6C-39F9-4689-B95A-EDB7FDB97E9D @default.
- Q67124194 P3098 Q67124194-68E76E80-BB1A-4222-9CC4-98B0FF350715 @default.
- Q67124194 P31 Q67124194-D44C8D84-2F6B-4F8A-9144-AFD833C871D2 @default.
- Q67124194 P580 Q67124194-F2F1280F-1936-43EC-A912-BFE1D281DC9B @default.
- Q67124194 P582 Q67124194-48BA724F-F6A9-4C58-977A-FDAC9F28B7E6 @default.
- Q67124194 P6099 Q67124194-F9890794-4C08-44ED-AD23-5357692D383A @default.
- Q67124194 P8363 Q67124194-30A18DAA-4E4A-4650-8B44-8262F4CD32EB @default.
- Q67124194 P1050 Q208414 @default.
- Q67124194 P1132 "+100" @default.
- Q67124194 P1476 "A Phase 2, Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma" @default.
- Q67124194 P2899 "+16" @default.
- Q67124194 P3098 "NCT04052997" @default.
- Q67124194 P31 Q30612 @default.
- Q67124194 P580 "2019-09-30T00:00:00Z" @default.
- Q67124194 P582 "2021-11-30T00:00:00Z" @default.
- Q67124194 P6099 Q42824440 @default.
- Q67124194 P8363 Q78089383 @default.